Windtree Announces Initiation of Financial Restructuring Program
WARRINGTON, Pa., Aug. 18, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has initiated a financial restructuring program intended to result...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]cturing-program-300506384.html
